Archives of Pediatric Infectious Diseases

Published by: Kowsar

The Synergic Activity of Eucalyptus Leaf Oil and Silver Nanoparticles Against Some Pathogenic Bacteria

Maryam Asghar Heydari 1 , Masoud Mobini 1 and Mohammad Salehi 2 , 3 , *
Authors Information
1 MS.c, Young Researchers and Elites Club, Tonekabon Branch, Islamic Azad University, Tonekabon, Iran
2 Blood Borne Infections Research Center, Academic Center for Education, Culture and Research (ACECR), Razavi Khorasan Branch, Mashhad, Iran
3 Medical Diagnostic Laboratory of Neyshabour, Center of Medical, Pathological and Genetic Diagnostic Services, Iranian Academic Center for Education, Culture and Research (ACECR), Mashhad Branch, Mashhad, IR Iran
Article information
  • Archives of Pediatric Infectious Diseases: October 2017, 5 (4); e61654
  • Published Online: October 2, 2017
  • Article Type: Research Article
  • Received: July 26, 2016
  • Revised: January 5, 2016
  • Accepted: November 8, 2016
  • DOI: 10.5812/pedinfect.61654

To Cite: Asghar Heydari M, Mobini M, Salehi M. The Synergic Activity of Eucalyptus Leaf Oil and Silver Nanoparticles Against Some Pathogenic Bacteria, Arch Pediatr Infect Dis. 2017 ; 5(4):e61654. doi: 10.5812/pedinfect.61654.

Abstract
Copyright © 2017, Archives of Pediatric Infectious Diseases. This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.
1. Background
2. Objectives
3. Methods
4. Results
5. Discussion
Acknowledgements
Footnotes
References
  • 1. Powers JH. Antimicrobial drug development--the past, the present, and the future. Clin Microbiol Infect. 2004; 10 Suppl 4: 23-31[DOI][PubMed]
  • 2. Rizzello L, Pompa PP. Nanosilver-based antibacterial drugs and devices: mechanisms, methodological drawbacks, and guidelines. Chem Soc Rev. 2014; 43(5): 1501-18[DOI][PubMed]
  • 3. Spellberg B. Dr. William H. Stewart: mistaken or maligned? Clin Infect Dis. 2008; 47(2): 294[DOI][PubMed]
  • 4. Spellberg B, Guidos R, Gilbert D, Bradley J, Boucher HW, Scheld WM, et al. The epidemic of antibiotic-resistant infections: a call to action for the medical community from the Infectious Diseases Society of America. Clin Infect Dis. 2008; 46(2): 155-64[DOI][PubMed]
  • 5. Fauci AS. Infectious diseases: considerations for the 21st century. Clin Infect Dis. 2001; 32(5): 675-85[DOI][PubMed]
  • 6. Fauci AS. Emerging and reemerging infectious diseases: the perpetual challenge. Acad Med. 2005; 80(12): 1079-85[PubMed]
  • 7. Morens DM, Folkers GK, Fauci AS. The challenge of emerging and re-emerging infectious diseases. Nature. 2004; 430(6996): 242-9[DOI][PubMed]
  • 8. Andersson DI, Hughes D. Antibiotic resistance and its cost: is it possible to reverse resistance? Nat Rev Microbiol. 2010; 8(4): 260-71[DOI][PubMed]
  • 9. Levin BR, Rozen DE. Non-inherited antibiotic resistance. Nat Rev Microbiol. 2006; 4(7): 556-62[DOI][PubMed]
  • 10. Schwaber MJ, De-Medina T, Carmeli Y. Epidemiological interpretation of antibiotic resistance studies - what are we missing? Nat Rev Microbiol. 2004; 2(12): 979-83[DOI][PubMed]
  • 11. Levy SB, Marshall B. Antibacterial resistance worldwide: causes, challenges and responses. Nat Med. 2004; 10(12 Suppl)-9[DOI][PubMed]
  • 12. Boucher HW. Challenges in anti-infective development in the era of bad bugs, no drugs: a regulatory perspective using the example of bloodstream infection as an indication. Clin Infect Dis. 2010; 50 Suppl 1-9[DOI][PubMed]
  • 13. Boucher HW, Talbot GH, Bradley JS, Edwards JE, Gilbert D, Rice LB, et al. Bad bugs, no drugs: no ESKAPE! An update from the Infectious Diseases Society of America. Clin Infect Dis. 2009; 48(1): 1-12[DOI][PubMed]
  • 14. Roberts L, Simpson S. Drug resistance. Deadly defiance. Introduction to special issue. Science. 2008; 321(5887): 355[DOI][PubMed]
  • 15. Kresse H, Belsey MJ, Rovini H. The antibacterial drugs market. Nat Rev Drug Discov. 2007; 6(1): 19-20[DOI][PubMed]
  • 16. Projan SJ, Shlaes DM. Antibacterial drug discovery: is it all downhill from here? Clin Microbiol Infect. 2004; 10 Suppl 4: 18-22[DOI][PubMed]
  • 17. Baker-Austin C, Wright MS, Stepanauskas R, McArthur JV. Co-selection of antibiotic and metal resistance. Trends Microbiol. 2006; 14(4): 176-82[DOI][PubMed]
  • 18. Whitesides GM. Nanoscience, nanotechnology, and chemistry. Small. 2005; 1(2): 172-9[DOI][PubMed]
  • 19. Marambio-Jones C, Hoek EMV. A review of the antibacterial effects of silver nanomaterials and potential implications for human health and the environment. J Nanoparticle Res. 2010; 12(5): 1531-51[DOI]
  • 20. Devi LS, Joshi SR. Antimicrobial and synergistic effects of silver nanoparticles synthesized using soil fungi of high altitudes of eastern himalaya. Mycobiology. 2012; 40(1): 27-34[DOI][PubMed]
  • 21. Scandorieiro S, de Camargo LC, Lancheros CA, Yamada-Ogatta SF, Nakamura CV, de Oliveira AG, et al. Synergistic and Additive Effect of Oregano Essential Oil and Biological Silver Nanoparticles against Multidrug-Resistant Bacterial Strains. Front Microbiol. 2016; 7: 760[DOI][PubMed]
  • 22. Delaquis PJ, Stanich K, Girard B, Mazza G. Antimicrobial activity of individual and mixed fractions of dill, cilantro, coriander and eucalyptus essential oils. Int J Food Microbiol. 2002; 74(1-2): 101-9[PubMed]
  • 23. Sartorelli P, Marquioreto AD, Amaral-Baroli A, Lima ME, Moreno PR. Chemical composition and antimicrobial activity of the essential oils from two species of Eucalyptus. Phytother Res. 2007; 21(3): 231-3[DOI][PubMed]
  • 24. O. Oyedeji A, Ekundayo O, Olawore ON, Adeniyi BA, Koenig WA. Antimicrobial activity of the essential oils of five Eucalyptus species growing in Nigeria. Fitoterapia. 1999; 70(5): 526-8[DOI]
  • 25. Hendry ER, Worthington T, Conway BR, Lambert PA. Antimicrobial efficacy of eucalyptus oil and 1,8-cineole alone and in combination with chlorhexidine digluconate against microorganisms grown in planktonic and biofilm cultures. J Antimicrob Chemother. 2009; 64(6): 1219-25[DOI][PubMed]
  • 26. Trivedi NA, Hotchandani SC. A study of the antimicrobial activity of oil of Eucalyptus. Indian J Pharmacol. 2004; 36(2): 93
  • 27. Performance standards for antimicrobial disk susceptibility test. Approved standard M02-A10. 2009;
  • 28. Methods for Dilution Antimicrobial Susceptibility Tests f or Bacteria That Grow Aerobically;Approved St andard-Ninth Edition. CLSI document M07-A9. 2012;
  • 29. Mirzaei F, Salouti M, Shapouri R, Heidari Z. Antimicrobial effect of plant peptide MBP-1 and silver nanoparticles, along with their synergistic effect on skin infection due to Pseudomonas aeruginosa: in vitro and animal model. Pajoohandeh J. 2013; 18(2): 64-8
  • 30. Sharifi-Rad J, Hoseini Alfatemi S, Sharifi Rad M, Iriti M. Antimicrobial Synergic Effect of Allicin and Silver Nanoparticles on Skin Infection Caused by Methicillin-Resistant Staphylococcus aureus spp. Ann Med Health Sci Res. 2014; 4(6): 863-8[DOI][PubMed]
  • 31. Naghsh N, Ghiasian M, Soleymani S, Torkan S. Investigation of Eucalyptus and nanosilver as a new nanomixture for growth inhibition of E. coli. Int J Mol Clin Microbiol. 2012; 2(1): 138-40
  • 32. Naghsh N, Ghyasiyan M, Soleimani S, Torkan S. Comparison between alcoholic eucalyptus and nano-silver as a new nanocomposition in growth inhibition of Aspergilus niger. Indian J Sci Technol. 2012; 5: 2445-7
  • 33. Leid JG, Ditto AJ, Knapp A, Shah PN, Wright BD, Blust R, et al. In vitro antimicrobial studies of silver carbene complexes: activity of free and nanoparticle carbene formulations against clinical isolates of pathogenic bacteria. J Antimicrob Chemother. 2012; 67(1): 138-48[DOI][PubMed]
  • 34. Sheikholeslami S, Mousavi SE, Ahmadi Ashtiani HR, Hosseini Doust SR, Mahdi Rezayat S. Antibacterial Activity of Silver Nanoparticles and Their Combination with Zataria multiflora Essential Oil and Methanol Extract. Jundishapur J Microbiol. 2016; 9(10)[DOI][PubMed]
  • 35. Narayanan KB, Sakthivel N. Green synthesis of biogenic metal nanoparticles by terrestrial and aquatic phototrophic and heterotrophic eukaryotes and biocompatible agents. Adv Colloid Interface Sci. 2011; 169(2): 59-79[DOI][PubMed]
  • 36. Martinez-Castanon GA, Nino-Martinez N, Martinez-Gutierrez F, Martinez-Mendoza JR, Ruiz F. Synthesis and antibacterial activity of silver nanoparticles with different sizes. J Nanoparticle Res. 2008; 10(8): 1343-8[DOI]
  • 37. Lara HH, Garza-Trevino EN, Ixtepan-Turrent L, Singh DK. Silver nanoparticles are broad-spectrum bactericidal and virucidal compounds. J Nanobiotechnology. 2011; 9: 30[DOI][PubMed]
  • 38. Musee N, Thwala M, Nota N. The antibacterial effects of engineered nanomaterials: implications for wastewater treatment plants. J Environ Monit. 2011; 13(5): 1164-83[DOI][PubMed]
  • 39. Allahverdiyev AM, Abamor ES, Bagirova M, Rafailovich M. Antimicrobial effects of TiO(2) and Ag(2)O nanoparticles against drug-resistant bacteria and leishmania parasites. Future Microbiol. 2011; 6(8): 933-40[DOI][PubMed]
  • 40. Guzman M, Dille J, Godet S. Synthesis and antibacterial activity of silver nanoparticles against gram-positive and gram-negative bacteria. Nanomedicine. 2012; 8(1): 37-45[DOI][PubMed]
  • 41. Thill A, Zeyons O, Spalla O, Chauvat F, Rose J, Auffan M, et al. Cytotoxicity of CeO2 nanoparticles for Escherichia coli. Physico-chemical insight of the cytotoxicity mechanism. Environ Sci Technol. 2006; 40(19): 6151-6[PubMed]
  • 42. Soenen SJ, Rivera-Gil P, Montenegro JM, Parak WJ, De Smedt SC, Braeckmans K. Cellular toxicity of inorganic nanoparticles: Common aspects and guidelines for improved nanotoxicity evaluation. Nano Today. 2011; 6(5): 446-65[DOI]
  • 43. Nel AE, Madler L, Velegol D, Xia T, Hoek EM, Somasundaran P, et al. Understanding biophysicochemical interactions at the nano-bio interface. Nat Mater. 2009; 8(7): 543-57[DOI][PubMed]
Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .

Search Relations:

Author(s):

Article(s):

Create Citiation Alert
via Google Reader

Readers' Comments